Educating clinicians on the latest government clinical guidance has been an important way for Federal agencies to ensure healthcare providers adopt evidence-based best practices. Medscape Education has been developing and delivering accredited education programs for CDC, NIH, FDA, and other HHS agencies for over ten years. Following significant investment in proprietary technologies and methodologies, Medscape Education has redefined its strategies for identifying, engaging, delivering, and measuring accredited educational activities.  The groundbreaking approach drives precision targeting, guaranteed reach, and a true public health impact.

Drawing on almost three decades of educating healthcare professionals, Medscape has accumulated a wealth of data. By combining our first-party data with third-party claims data and leveraging cutting-edge machine learning technology, we are not just reporting metrics but delivering data-driven narratives on the changes that resonate with all stakeholders. These changes are driven by the Medscape Precision User Learning and Segmentation engine, PULSE, which integrates claims data, AMA data, and 30 years of Medscape data, reaching the target audience best positioned to have the greatest impact on patient outcomes.

While the PUSLE engine is new, Medscape has delivered precision targeting and impactful change for agencies like the FDA. In 2016, the FDA asked Medscape if they could develop a program to educate clinicians about fluoroquinolones, a class of antibiotics that can have serious side effects.  Using claims data, we targeted high prescribers of fluoroquinolones, directing them to educational material about side effects. 

Using a controlled/exposed methodology, short-form messaging, CME, and baseline and post-campaign claims data, we were able to measure the true impact of the campaign, which resulted in a 21.7% reduction in fluoroquinolone prescribing.  What made the difference in this campaign?   Precise messaging and education directed to those prescribers most likely to change their behaviors.  

February 8, 2024 – The Society for Health Communication, a member-driven organization working to advance the science of health communication, elected its 2024 Executive Leadership Team, three new Steering Committee members for the 2024-2025 term, and appointed a new Executive Director. Ashani Johnson-Turbes, PhD, Vice President, NORC at the University of Chicago has been elected as 2024 President, Stacy Robison, MPH, CHES, President and Co-Founder, CommunicateHealth as Vice President, and Stephanie Miles, PhD, Deputy Director, Communication Research, Fors Marsh as Secretary and Member-at-Large.

Johnson-Turbes previously served as Vice President and now chairs the Society’s Steering Committee. She partners with Robison to achieve the Society’s mission and vision, diversity, equity and inclusion, and overall growth goals. Miles will focus on organizational member engagement and retention and manage the Society’s Advisory Board.

Following an open nomination and review process, the Society appointed three new Steering Committee members for the 2024-2025 term:

Partnership seeks to foster development and sharing of learnings, evidence, and research

The Journal of Health Communication becomes an official publication of the Society 

Austin, TX and New York, NY (January 24, 2024) – The Society for Health Communication, a member-driven organization working to advance the science of health communication has forged a new partnership with the Journal of Health Communication, the highest-rated academic journal in the field. This partnership will help increase the field’s access to critical health communication research, science, and practice learnings; create new publication opportunities; and advance public health. 

Appointments reflect continued organizational growth and essential role of health communicators

February 7, 2022 – The Society for Health Communication, a member-driven organization working to advance the science of health communication, has elected Michael Grela, EVP, Head of Reputation and Social Impact, Evoke KYNE, as its 2022 President, and re-elected Shelly Spöeth, Principal Associate, Abt Associates, as its 2022 Member-at-Large. Grela is responsible for overseeing its newly-expanded Steering Committee and partnering with Executive Director Diane Brodalski and leadership to set and achieve its member engagement, diversity, equity and inclusion, and overall growth goals. Spöeth will focus on organizational member engagement and retention, and management of its Advisory Board.